# Adverse Event Data Collection From External Registries on Nonacog Beta Pegol

> **NCT03690336** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 10 (estimated)

## Conditions studied

- Haemophilia B

## Interventions

- **DRUG:** Nonacog beta pegol

## Key facts

- **NCT ID:** NCT03690336
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-10-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03690336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03690336, "Adverse Event Data Collection From External Registries on Nonacog Beta Pegol". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03690336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*